{"id":"https://openalex.org/W349331059","doi":null,"title":"Identification of the Her-2 Functional Site: Blockage of Receptor Heterodimerization","display_name":"Identification of the Her-2 Functional Site: Blockage of Receptor Heterodimerization","publication_year":2007,"publication_date":"2007-09-01","ids":{"openalex":"https://openalex.org/W349331059","mag":"349331059"},"language":"en","primary_location":{"id":"pmh:ADA478663","doi":null,"is_oa":false,"landing_page_url":"http://oai.dtic.mil/oai/oai?&verb=getRecord&metadataPrefix=html&identifier=ADA478663","pdf_url":null,"source":{"id":"https://openalex.org/S4406923043","display_name":"Defense Technical Information Center (DTIC)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"DTIC","raw_type":"Text"},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5012328790","display_name":"Ruth Lupu","orcid":"https://orcid.org/0000-0002-5564-3172","observed_orcids":["https://orcid.org/0000-0002-5564-3172"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Lupu, Ruth","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5012328790"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/her2","display_name":"HER2","score":0.9449999928474426},{"id":"https://openalex.org/keywords/receptor-heterodimerization","display_name":"receptor heterodimerization","score":0.8960000276565552},{"id":"https://openalex.org/keywords/neuregulin-1","display_name":"neuregulin-1","score":0.9279999732971191},{"id":"https://openalex.org/keywords/her2-targeted-therapy","display_name":"HER2-targeted therapy","score":0.8259999752044678},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.8840000033378601},{"id":"https://openalex.org/keywords/oncogenic-signaling","display_name":"oncogenic signaling","score":0.7689999938011169}],"concepts":[{"id":"https://openalex.org/C169822122","wikidata":"https://www.wikidata.org/wiki/Q230187","display_name":"Crosstalk","level":2,"score":0.7809455394744873},{"id":"https://openalex.org/C185323287","wikidata":"https://www.wikidata.org/wiki/Q59252204","display_name":"Neuregulin","level":3,"score":0.6635880470275879},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.6517664194107056},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4943675994873047},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.4520043730735779},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.438865065574646},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4156700074672699},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.3529950678348541},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3153921961784363},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.21891272068023682},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:ADA478663","doi":null,"is_oa":false,"landing_page_url":"http://oai.dtic.mil/oai/oai?&verb=getRecord&metadataPrefix=html&identifier=ADA478663","pdf_url":null,"source":{"id":"https://openalex.org/S4406923043","display_name":"Defense Technical Information Center (DTIC)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"DTIC","raw_type":"Text"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.6240000128746033,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":41,"referenced_works":["https://openalex.org/W188996788","https://openalex.org/W1601571585","https://openalex.org/W1870193477","https://openalex.org/W1966658428","https://openalex.org/W1974024530","https://openalex.org/W1974088439","https://openalex.org/W1985036391","https://openalex.org/W1992785655","https://openalex.org/W1996372431","https://openalex.org/W2004490932","https://openalex.org/W2006174096","https://openalex.org/W2009218955","https://openalex.org/W2009578901","https://openalex.org/W2014457594","https://openalex.org/W2022406746","https://openalex.org/W2024651005","https://openalex.org/W2040142253","https://openalex.org/W2058620780","https://openalex.org/W2062713892","https://openalex.org/W2064031693","https://openalex.org/W2067276829","https://openalex.org/W2068125497","https://openalex.org/W2069526613","https://openalex.org/W2070803253","https://openalex.org/W2074270635","https://openalex.org/W2082431893","https://openalex.org/W2108795463","https://openalex.org/W2111580206","https://openalex.org/W2122008479","https://openalex.org/W2123646476","https://openalex.org/W2125797780","https://openalex.org/W2126721728","https://openalex.org/W2139135964","https://openalex.org/W2141167338","https://openalex.org/W2141393790","https://openalex.org/W2143600397","https://openalex.org/W2145477245","https://openalex.org/W2154568434","https://openalex.org/W2157208434","https://openalex.org/W2158077354","https://openalex.org/W2169782526"],"related_works":["https://openalex.org/W2086860209","https://openalex.org/W2216779694","https://openalex.org/W4372342600","https://openalex.org/W1514463309","https://openalex.org/W2157884341","https://openalex.org/W6958783971","https://openalex.org/W1488797338","https://openalex.org/W2333299318","https://openalex.org/W2149301081","https://openalex.org/W2114831668"],"abstract_inverted_index":{"Targeting":[0],"HER2":[1,55,79,92,130,139],"is":[2,57,134],"not":[3],"as":[4,6],"straightforward":[5],"it":[7],"was":[8],"originally":[9],"predicted":[10],"since":[11],"many":[12],"breast":[13],"tumors":[14],"express":[15],"multiple":[16],"HER":[17,24],"receptors":[18],"and":[19,77,83,99,107,141,150],"co-express":[20],"one":[21],"or":[22,155],"more":[23],"ligands.":[25],"This":[26],"cross-talk":[27],"network":[28],"negatively":[29],"impacts":[30],"the":[31,34,40,54,97,120,138,175],"response":[32],"to":[33,66,75,96,170],"currently":[35],"used":[36],"HER2-targeted":[37],"agents,":[38],"highlighting":[39],"urgent":[41],"need":[42],"for":[43,159,174],"a":[44,49,110,152,165],"novel":[45],"anti-HER2":[46],"molecule(s)":[47],"presenting":[48],"combination":[50],"strategy.":[51],"Activation":[52],"of":[53,109,123,136,146,177],"receptor":[56,63,105],"attained":[58],"by":[59,73,90],"several":[60],"means:":[61],"1)":[62],"overexpression":[64],"leads":[65],"homodimerization;":[67],"2)":[68],"EGF":[69],"induces":[70,87],"EGFR-HER2":[71],"hetero-dimerization":[72,89],"binding":[74,95],"EGFR":[76],"inducing":[78,104],"activation":[80,108,145],"via":[81,93],"crosstalk;":[82],"3)":[84],"Heregulin":[85],"(HRG)":[86],"HER3-HER2":[88],"activating":[91,126],"its":[94],"HER3":[98],"HER4":[100],"receptors,":[101],"in":[102],"turn":[103],"crosstalk":[106],"signaling":[111,149],"cascade.":[112],"In":[113],"short,":[114],"our":[115,171],"preliminary":[116],"study":[117],"reveals":[118],"that":[119],"specific":[121],"disruption":[122],"an":[124],"essential":[125],"sequence":[127],"existing":[128],"on":[129],"ECD":[131],"domain":[132],"III":[133],"capable":[135],"disabling":[137],"homo-":[140],"hetero-dimerization,":[142],"thus":[143],"blocking":[144],"HER2-driven":[147],"oncogenic":[148],"generating":[151],"dominant-negative":[153],"Peptides":[154],"compounds":[156],"with":[157],"specificity":[158],"this":[160],"functional":[161],"site":[162],"should":[163],"add":[164],"previously":[166],"unrecognized":[167],"molecular":[168],"approach":[169],"therapeutic":[172],"arsenal":[173],"management":[176],"HER2-overexpressing":[178],"carcinomas.":[179]},"counts_by_year":[],"updated_date":"2026-08-26T07:47:46.906454","created_date":"2025-10-10T00:00:00"}